Here's What You Should Know About The Finance World Today
"U.S. stocks retreated on Tuesday as a spate of tepid corporate earnings weighed on the broader market.
Cytokinetics Inc (CYTK)
Market is closed
News
- First
- << Previous
- 51 - 60
- Next >>
Cytokinetics, Inc. (CYTK) Hedge Funds Are Snapping Up
Looking for high-potential stocks? Just follow the big players within the hedge fund industry.
Cytokinetics Inc (CYTK): Mark Lampert's Biotechnology Value Fund Loads Up On More Shares
Mark Lampert's Biotechnology Value Fund has filed a Form 13G on Cytokinetics, Inc. (NASDAQ:CYTK), one of its top-10 holdings at the end of 2015.
Hedge Funds Are Buying Cytokinetics, Inc. (CYTK)
Before we spend many hours researching a company, we'd like to analyze what hedge funds and billionaire investors think of the stock first.
Cytokinetics, Inc. (CYTK) Conference Call Transcript - Expansion of Collaboration Agreement with Astellas
Good morning and welcome ladies and gentlemen to this Cytokinetics conference call.
New Changes in SAC Capital's 13F Portfolio: Annies Inc (BNNY), Cytokinetics, Inc. (CYTK) And Other
In another round of filings with the Securities and Exchange Commission, Steven Cohen and his fund, SAC Capital Advisors, have disclosed 4 new moves: reductions in the ownership of Annies Inc (NYSE:BNNY...
Mark Lampert, Biotechnology Value Fund Up Stake In Cytokinetics, Inc. (CYTK), Reduce Exposure To Regado Biosciences Inc (RGDO)
Mark Lampert, the founder and manager of Biotechnology Value Fund, is bullish on Cytokinetics, Inc. (NASDAQ:CYTK).
Hedge Funds Are Selling BioDelivery Sciences International, Inc. (BDSI)
At the moment, there are many indicators market participants can use to watch their holdings. Two of the most under-the-radar are hedge fund and insider trading activity.
This Metric Says You Are Smart to Buy Amicus Therapeutics, Inc. (FOLD)
Now, according to many investors, hedge funds are assumed to be overrated, outdated investment tools of an era lost to time.
Aegerion Pharmaceuticals, Inc. (AEGR): Cheers and Jeers for Amgen, Inc. (AMGN)'s Pipeline
Just after the successful acquisition of Onyx Pharmaceuticals and positive results on AMG-145, a cholesterol-lowering experimental drug, Amgen, Inc.
- First
- << Previous
- 51 - 60
- Next >>
Billionaire Hedge Funds
